HHS Harte-Hanks, Inc.

  1. Stocks
  2. Industrials
  3. NASDAQ: HHS

Price (delayed)

$2.19

Market cap

$16.25M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.14

Enterprise value

$33.73M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 48

Harte Hanks is a global experience company that seamlessly blends data-driven insight, omnichannel marketing, logistics, customer care, fulfillment, and logistics solutions to help brands connect with and serve their customers. ...

Highlights
The debt is down by 7% YoY
The EPS has soared by 97% YoY but it has contracted by 27% from the previous quarter
Harte-Hanks's net income has soared by 97% YoY but it has decreased by 29% from the previous quarter
The revenue has declined by 14% year-on-year and by 2.7% since the previous quarter
The gross profit has contracted by 13% YoY
Sector: Industrials
Industry: Conglomerates
Website: http://www.hartehanks.com

Key stats

What are the main financial stats of HHS

HHS stock price

How has the Harte-Hanks stock price performed over time
Intraday
-3.52%
1 week
-8.37%
1 month
1.39%
1 year
-35.78%
YTD
-27.24%
QTD
1.39%

Financial performance

How have Harte-Hanks's revenue and profit performed over time
Revenue
$155.27M
Gross profit
$108.09M
Operating income
-$342,000
Net income
-$1.05M
Gross margin
69.6%
Net margin
-0.7%
The operating margin has dropped by 200% since the previous quarter and by 122% year-on-year
HHS's operating income has dropped by 189% since the previous quarter and by 120% year-on-year
Harte-Hanks's net income has soared by 97% YoY but it has decreased by 29% from the previous quarter
The net margin has soared by 96% YoY but it is down by 40% QoQ

Price vs fundamentals

How does HHS's price correlate with its fundamentals

Growth

What is Harte-Hanks's growth rate over time

Valuation

What is Harte-Hanks stock price valuation
P/E
N/A
P/B
0.81
P/S
0.1
EV/EBIT
N/A
EV/EBITDA
10.05
EV/Sales
0.22
The EPS has soared by 97% YoY but it has contracted by 27% from the previous quarter
HHS's P/B is 33% lower than its last 4 quarters average of 1.2
HHS's equity is down by 6% year-on-year and by 2.1% since the previous quarter
The stock's price to sales (P/S) is 67% less than its 5-year quarterly average of 0.3
The revenue has declined by 14% year-on-year and by 2.7% since the previous quarter

Efficiency

How efficient is Harte-Hanks business performance
The ROS has soared by 97% YoY but it has contracted by 40% from the previous quarter
Harte-Hanks's return on invested capital has surged by 97% YoY but it has shrunk by 50% QoQ
The return on equity has surged by 96% year-on-year but it has declined by 31% since the previous quarter
The ROA has soared by 96% YoY but it has decreased by 22% QoQ

Dividends

What is HHS's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history

Special dividends are included in TTM DPS and yield

Financial health

How did Harte-Hanks financials performed over time
HHS's total assets is 29% higher than its total liabilities
The total liabilities has declined by 11% year-on-year
HHS's total assets is down by 10% YoY
The debt is 10% higher than the equity
The debt is down by 7% YoY
HHS's equity is down by 6% year-on-year and by 2.1% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.